Cargando…
Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry
BACKGROUND: Romiplostim is a thrombopoietin‐mimetic peptibody for adult refractory chronic immune thrombocytopenia (ITP). We aimed to describe ITP patients receiving romiplostim, platelet counts and romiplostim usage in UK clinical practice. METHODS: This was a retrospective cohort study of patients...
Autores principales: | Doobaree, Indraraj Umesh, Newland, Adrian, McDonald, Vickie, Nandigam, Raghava, Mensah, Lesley, Leroy, Sandrine, Seesaghur, Anouchka, Patel, Hitan, Wetten, Sally, Provan, Drew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850028/ https://www.ncbi.nlm.nih.gov/pubmed/30758874 http://dx.doi.org/10.1111/ejh.13221 |
Ejemplares similares
-
Proposal for a New Protocol for the Management of Immune Thrombocytopenia (ITP)
por: González-López, Tomás José, et al.
Publicado: (2022) -
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies
por: Kuter, David J., et al.
Publicado: (2019) -
Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects
por: Jawa, Vibha, et al.
Publicado: (2010) -
Immune thrombocytopenia (ITP) World Impact Survey (I‐WISh): Impact of ITP on health‐related quality of life
por: Cooper, Nichola, et al.
Publicado: (2020) -
Long-Term Use of the Thrombopoietin-Mimetic Romiplostim in Children With Severe Chronic Immune Thrombocytopenia (ITP)
por: Bussel, James B, et al.
Publicado: (2015)